Zurich Cantonal Bank
CBIO

Zurich Cantonal Bank’s Crescent Biopharma CBIO Stock Holding History

Zurich Cantonal Bank’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-20
Closed -$8K – 2604
2019
Q3 		$8K Hold
20
– – ﹤0.01% 2567
2019
Q2 		$24K Hold
20
– – ﹤0.01% 2414
2019
Q1 		$25K Sell
20
-17
-46% -$19.5K ﹤0.01% 2345
2018
Q4 		$35K Hold
37
– – ﹤0.01% 2226
2018
Q3 		$53K Buy
37
+13
+54% +$19.7K ﹤0.01% 2125
2018
Q2 		$39K Buy
+24
New +$41.3K ﹤0.01% 2259

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Zurich Cantonal Bank's CBIO Position: Q4 2019 in Review

Zurich Cantonal Bank sold out of Crescent Biopharma (CBIO) in Q4 2019, closing a stake of 20 shares — an estimated $8K sold.

Zurich Cantonal Bank first reported a position in CBIO in Q2 2018 and held it in 6 quarters. The position peaked at $53K in Q3 2018. 78 funds tracked by Wall St. Rank hold CBIO as of Q4 2019.

  • Zurich Cantonal Bank reported no remaining Crescent Biopharma position as of Q4 2019 after selling out during the quarter.
  • Zurich Cantonal Bank sold 20 Crescent Biopharma shares in Q4 2019, an estimated $8K.
  • Zurich Cantonal Bank first reported a position in Crescent Biopharma in Q2 2018 and held it in 6 quarters.
  • Zurich Cantonal Bank's Crescent Biopharma position peaked at $53K in Q3 2018.
  • 78 funds tracked by Wall St. Rank held Crescent Biopharma as of Q4 2019.

Based on Zurich Cantonal Bank's 13F filing for Q4 2019, filed 21 Jan 2020.